Clinical Trial Update: Kinetics of Fluvoxamine and Digoxin in Subjects With Different MDR1 Genotypes [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study evaluating how fluvoxamine and digoxin are affected by different MDR1 genotypes; the study has completed in subjects with depressi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• DIGOXIN (Digoxin)
• Fluvoxamine (fluvoxamine)

Snippet

Sponsor: Karolinska Institutet | Conditions: Depression | Phase 1 | Status: COMPLETED